Skip to main content
Premium Trial:

Request an Annual Quote

New Products Posted to GenomeWeb: Oxford Nanopore, Invivoscribe, Precipio, More

Oxford Nanopore MinKnow Software

Oxford Nanopore Technologies has released an updated version of its MinKnow software, which controls its MinIon, GridIon, and PromethIon sequencing platforms. Among other changes, the new version includes a feature called "progressive unblock," which helps increase the data yield of a flow cell, as well as active voltage control, which improves signal consistency during a run, the company said.


Invivoscribe LymphoTrack Dx TRB Assay

InvivoScribe Technologies has released its LymphoTrack Dx TRB Assay for the Illumina MiSeq platform, a CE-marked next-generation sequencing kit for in vitro diagnostic use. The assay completes the menu of Invivoscribe's CE-marked clonality assays on the MiSeq, enabling small and large laboratories to identify and track clonal rearrangements.


Precipio KRAS Liquid Biopsy Kits for Pancreatic Cancer

Precipio has launched two new research-use only ICEme kits for the detection of mutations in KRAS Exons 2 and 3 in pancreatic cancer. The kits use the company's proprietary ICE-COLD PCR liquid biopsy technology and are available for both qPCR and Sanger sequencing platforms. According to Precipio, its non-invasive, low-cost enrichment technology is well-suited for laboratories developing screening and monitoring tests. The kits will be priced at approximately $100 per specimen.


For more new products and services, please visit the New Products page on our website.